Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

U.S. FDA Opens First Office In India, A “Portal” To The Agency

This article was originally published in PharmAsia News

Executive Summary

U.S. Health and Human Services Secretary Michael Leavitt and U.S. FDA Commissioner Andrew von Eschenbach announced Jan. 15 the opening of FDA's first office in India, which will be in New Delhi. An FDA official told PharmAsia News the agency is awaiting permission from India to open a second office in Mumbai

You may also be interested in...



U.S. FDA Readies India Staffing; Says India Office To Enhance Speed And Effectiveness Of Regulatory Cooperation

MUMBAI - U.S. FDA has hand picked a few top notch professionals from its global headquarters for positions at the newly planned Mumbai and New Delhi offices. Over the years, these officers have gained experience in drug regulation and investigations through several global postings

U.S. FDA Readies India Staffing; Says India Office To Enhance Speed And Effectiveness Of Regulatory Cooperation

MUMBAI - U.S. FDA has hand picked a few top notch professionals from its global headquarters for positions at the newly planned Mumbai and New Delhi offices. Over the years, these officers have gained experience in drug regulation and investigations through several global postings

FDA international commissioner appointed

FDA appoints Lou Valdez as associate commissioner for international programs, a role in which she will lead implementation of FDA's international programs. Valdez previously served as deputy director in the HHS Office of Global Health Affairs, where she led the development of U.S. government policy positions. She enters her new role at a time of significant expansion of the agency's international presence; in addition to the recent opening of offices in China, FDA announced the opening of its first office in India Jan. 15 (1PharmAsia News, Jan. 15, 2009)

Related Content

UsernamePublicRestriction

Register

SC069830

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel